Search - tctmd.com

Displaying 61 - 80 of 636

Sort: Relevancy | Date

Presentation TCT 2016

Surgical Approaches to LAA Closure: Techniques, Devices, and Results

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Marc Gillinov

October 30, 2016

Presentation TCT 2016

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Christopher B. Granger

October 30, 2016

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs?

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michelle O'Donoghue

October 30, 2016

Presentation TCT 2016

Impact of LAA Exclusion on Neurohormonal Modulation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Atrial Fibrillation: Scope of the Problem

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michael D. Ezekowitz

October 30, 2016

Presentation TCT 2016

Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned

Presenter: Matthew J. Price, Jason H. Rogers, Petr Neuzil

October 30, 2016

Presentation TCT 2016

Cases #5 and #6: Sheath Selection, Orientation, and Lobe Position to Optimize Occluder Deployment

Presenter: Matthew J. Price, Jason H. Rogers, Ramon Quesada

October 30, 2016

Presentation TCT 2016

Cases #3 and #4: Transseptal Puncture for LAA Closure - When Location Makes a Difference

Presenter: Matthew J. Price, Jason H. Rogers

October 30, 2016

Presentation TCT 2016

Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away

Presenter: Matthew J. Price, Jason H. Rogers, Jacqueline Saw

October 30, 2016

Presentation TCT 2016

Case #3: Transseptal Puncture for Left Atrial Appendage Closure

Presenter: Samir R. Kapadia, Horst Sievert, Brian K. Whisenant

October 30, 2016

Presentation TCT 2016

Rationale for and Case Examples of Combination Transcatheter Mitral Valve Repair Procedures and Left Atrial Appendage Closure

Presenter: Stephan Baldus, Vinod H. Thourani, Fabian Nietlispach

October 30, 2016

Presentation TCT 2016

Rationale for and Case Examples of Combination Transcatheter Mitral Valve and Left Atrial Appendage Closure

Presenter: Stephan Baldus, Vinod H. Thourani, Francesco Maisano

October 30, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Industry News

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

October 03, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Industry News

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

September 01, 2016

News Daily News

Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests

Todd Neale

July 28, 2016

Advertisement

Surgical Approaches to LAA Closure: Techniques, Devices, and Results

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs?

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance

Impact of LAA Exclusion on Neurohormonal Modulation

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Atrial Fibrillation: Scope of the Problem

Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned

Cases #5 and #6: Sheath Selection, Orientation, and Lobe Position to Optimize Occluder Deployment

Cases #3 and #4: Transseptal Puncture for LAA Closure - When Location Makes a Difference

Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away

Case #3: Transseptal Puncture for Left Atrial Appendage Closure

Rationale for and Case Examples of Combination Transcatheter Mitral Valve Repair Procedures and Left Atrial Appendage Closure

Rationale for and Case Examples of Combination Transcatheter Mitral Valve and Left Atrial Appendage Closure

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

TCTMD’s Top 10 Most Popular Stories for August 2016

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content